Communiqués Alamar Biosciences, Inc.

Actions

Temps réel estimé Cboe BZX Autres places de cotation 16:40:30 15/07/2026			Varia. 5j.	Varia. 1 janv.
27,18 ^USD	+0,50%		+7,23%	-

13/07	ALAMAR BIOSCIENCES, INC. : BofA Securities favorable sur le dossier	ZM
13/07	Alamar Biosciences s'associe à plusieurs universités de recherche pour un projet de biomarqueurs neurodégénératifs	MT

14/07	Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026	GL
13/07	Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases	GL
10/07	Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling	GL
07/07	Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research	GL
08/05	Alamar Biosciences Reports First Quarter 2026 Financial Results	GL
05/05	Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference	GL